Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins

J Immunol. 2005 Jul 15;175(2):796-805. doi: 10.4049/jimmunol.175.2.796.

Abstract

Many viral proteins that contain MHC class I-restricted peptides are long-lived, and it is elusive how they can give rise to class I epitopes. Recently, we showed that direct presentation of an epitope of the long-lived lymphocytic choriomeningitis virus nucleoprotein (LCMV-NP) required neosynthesis in accordance with the defective ribosomal products hypothesis. In this study, we report that LCMV-NP can be cross-primed in mice using either LCMV-NP-transfected human HEK293 or BALB/c-derived B8 cells as Ag donor cells. In addition, we establish that contrary to direct presentation, cross-presentation required accumulation of the mature LCMV-NP and could not be sustained by the newly synthesized LCMV-NP protein, intermediate proteasomal degradation products, or the minimal NP396 epitope. Nevertheless, NP cross-presentation was enhanced by heat shock and was blunted by inhibitors of heat shock protein 90 and gp96. We propose that cross-presentation has evolved to sustain the presentation of stable viral proteins when their neosynthesis has ceased in infected donor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / antagonists & inhibitors
  • Adjuvants, Immunologic / physiology*
  • Animals
  • Antigen-Presenting Cells / immunology
  • Antigen-Presenting Cells / metabolism
  • Antigens, Neoplasm / metabolism
  • Antigens, Neoplasm / physiology
  • Cell Death / immunology
  • Cell Death / radiation effects
  • Cell Line
  • Cross-Priming / immunology*
  • Female
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors
  • HSP90 Heat-Shock Proteins / physiology*
  • Heat-Shock Response / immunology
  • Humans
  • Lymphocytic choriomeningitis virus / immunology*
  • Mediator Complex
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Nuclear Proteins / immunology
  • Nuclear Proteins / metabolism
  • Nucleoproteins / biosynthesis*
  • Nucleoproteins / genetics
  • Nucleoproteins / immunology*
  • Nucleoproteins / metabolism
  • Peptide Fragments / biosynthesis*
  • Peptide Fragments / genetics
  • Peptide Fragments / immunology*
  • Peptide Fragments / metabolism
  • Proteasome Endopeptidase Complex / immunology
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Processing, Post-Translational / immunology
  • Ribosomal Proteins / antagonists & inhibitors
  • Ribosomal Proteins / biosynthesis
  • Ribosomal Proteins / physiology
  • Trans-Activators / immunology
  • Trans-Activators / metabolism
  • Transfection
  • Ultraviolet Rays

Substances

  • Adjuvants, Immunologic
  • Antigens, Neoplasm
  • DRIP, VDR interacting protein complex
  • HSP90 Heat-Shock Proteins
  • Mediator Complex
  • Nuclear Proteins
  • Nucleoproteins
  • Peptide Fragments
  • Ribosomal Proteins
  • Trans-Activators
  • nucleoprotein peptide 394-408, lymphocytic choriomeningitis virus
  • sarcoma glycoprotein gp96 rejection antigens
  • Proteasome Endopeptidase Complex